Cadre Holdings, Inc.

Cadre Holdings, Inc.(CDRE)股票分析

$27.050

-0.019 (-0.07%)收盤時

Loading chart…
最高
27.387
開盤
27.220
成交量加權均價
26.84
成交量
643.24K
市值
1.34B
最低
26.090
成交金額
17.27M
企業價值/稅息折舊攤銷前利潤(TTM)
12.07

Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others.

AI 分析 of Cadre Holdings, Inc. (CDRE)

買進

Cadre Holdings Inc is a good buy right now due to its recent positive performance and strong analyst ratings. The stock has seen a 7.45% increase over the last five days, and analysts have set a price target of $43, suggesting a potential upside of 63.1%. Additionally, the forward P/E ratio of 18.15 indicates that the stock may be undervalued compared to its growth prospects. However, the main risk is the recent insider selling by CEO Warren B. Kanders, who sold 75,000 shares, which could signal a lack of confidence in the company's near-term performance.

估值指標

Cadre Holdings, Inc.(CDRE)目前預期本益比為 18.15,5 年平均預期本益比為 30.24。

預期本益比

合理
5 年均值 P/E
30.24
目前P/E
18.15
高估
46.23
低估
14.26

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
13.22
目前EV/EBITDA
12.07
高估
15.05
低估
11.39

預期股價營收比

低估
5 年均值 P/S
2.01
目前P/S
1.43
高估
2.33
低估
1.68

Alphio AI 對 CDRE 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%CDRE

$34.59

情境價格

基

基準

基準 · 50%CDRE

$30.16

情境價格

悲

悲觀

悲觀 · 25%CDRE

$29.75

情境價格

持有 CDRE 的大戶

G

Greenhouse Funds LLLP

+ 持有CDRE

+4.62%

3個月報酬率

事件時間軸

2026-08-05 (ET)

16:30:00

Company Reports Q2 Revenue of $207.1M, Exceeding Expectations

16:30:00

Cadre Raises 2026 Sales Guidance to $749-$769 Million

2026-06-02 (ET)

16:20:00

Cadre Holdings Subsidiary Safariland Wins $61 Million FBI Contract

2026-05-11 (ET)

16:30:00

Cadre Reports Q1 Revenue of $155.4M, Exceeds Expectations

16:30:00

Company Confirms FY26 Adjusted EBITDA View of $136M-$141M

資訊

CDRE 常見問題 —— 由 Alphio AI 解答

Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others. It operates in the Industrials sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Cadre Holdings Inc is a good buy right now due to its recent positive performance and strong analyst ratings. The stock has seen a 7.45% increase over the last five days, and analysts have set a price target of $43, suggesting a potential upside of 63.1%. Additionally, the forward P/E ratio of 18.15 indicates that the stock may be undervalued compared to its growth prospects. However, the main risk is the recent insider selling by CEO Warren B. Kanders, who sold 75,000 shares, which could signal a lack of confidence in the company's near-term performance.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易